NDTVCenter·
Eli Lilly Launches Cancer Drug Tanstrive In India, Priced At Rs 2.15 Lakh Per Box
It is designed to selectively target RET alterations and block the abnormal signalling pathways that drive tumour growth.
Read at NDTV →
It is designed to selectively target RET alterations and block the abnormal signalling pathways that drive tumour growth.

<iframe src="https://hindustansphere.com/embed/cluster/dd6b6b05e7c968db485c0c8d9e75ff0337f52df4" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Eli Lilly Launches Cancer Drug Tanstrive In India, Priced At Rs 2.15 Lakh Per Box"></iframe>